2001
DOI: 10.5326/15473317-37-5-420
|View full text |Cite
|
Sign up to set email alerts
|

A multisite case report on the clinical use of sevoflurane in dogs

Abstract: The purpose of this report was to evaluate the clinical safety and efficacy of sevoflurane as an inhalant anesthetic in dogs. Subjective and objective data from 196 clinical cases utilizing sevoflurane as the maintenance anesthetic was collected at three sites. After preanesthetic evaluation, the attending anesthesiologist assigned the dogs to one of the following six anesthetic protocols: protocol 1, oxymorphone premedication and thiopental induction; protocol 2, oxymorphone/acetylpromazine premedication and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
3
10

Year Published

2003
2003
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(27 citation statements)
references
References 19 publications
0
14
3
10
Order By: Relevance
“…Sevoflurane usually causes a dose-dependent decrease in arterial blood pressure (Branson et al, 2001). Although, Rezende (2004) observed stability for MAP in dogs anesthetized with 1.5 MAC of sevoflurane, differing from this study that administered the same dose, but recorded, from T20 on, MAP values lower than at T0.…”
Section: Discussioncontrasting
confidence: 51%
See 1 more Smart Citation
“…Sevoflurane usually causes a dose-dependent decrease in arterial blood pressure (Branson et al, 2001). Although, Rezende (2004) observed stability for MAP in dogs anesthetized with 1.5 MAC of sevoflurane, differing from this study that administered the same dose, but recorded, from T20 on, MAP values lower than at T0.…”
Section: Discussioncontrasting
confidence: 51%
“…It's low bloodgas solubility coefficient (0.68) provides rapid anesthetic induction and recovery, with minimal irritation of the upper airways, low incidence of coughing and laryngospasm, fast control of anesthetic depth and preservation of the spontaneous ventilation (Charles and Fallon, 2000). This inhalant anesthetic has a dosedependent negative inotropic effect (Hanouz et al, 2000), increasing coronary blood flow and decreasing myocardial oxygen consumption (Crystal et al, 2000), but it decreases arterial blood pressure and systemic vascular resistance (Branson et al, 2001). …”
Section: Introductionmentioning
confidence: 99%
“…During the last decade, clinical use of sevoflurane has been spreading in veterinary species such as horses [8,12,18,27], cats [13] and dogs [5,6]. Sevoflurane is minimally metabolized and easily cleared in animals; however, it should be remembered that sevoflurane causes dose-dependent hypotension, hypoventilation, impaired cardiac contractility and hypothermia [16].…”
mentioning
confidence: 99%
“…During the last decade, clinical use of sevoflurane has been spreading in veterinary species such as horses [3,14,24,31], cats [15] and dogs [1,2]. Sevoflurane is minimally metabolized and easily cleared in animals; however, it should be remembered that sevoflurane causes dose-dependent hypotension, hypoventilation, impaired cardiac contractility and hypothermia [21].…”
mentioning
confidence: 99%
“…The tube passed through the endotracheal tube so that its tip rested in the thoracic portion of the trachea. A side-stream capnograph and anesthetic agent monitor were used to determine respiratory rate, PETCO 2 and ETSEV. The anesthetic agent monitor was calibrated immediately prior to each sevoflurane MAC determination.…”
mentioning
confidence: 99%